18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
and 16 19 16 19 O
above 20 25 20 25 O

Administration 0 14 26 40 O
of 15 17 41 43 O
antifungal 18 28 44 54 B-treatment
agents 29 35 55 61 I-treatment
( 36 37 62 63 O
itraconazole 37 49 63 75 B-treatment
, 49 50 75 76 O
fluconazole 51 62 77 88 B-treatment
, 62 63 88 89 O
etc 64 67 90 93 O
) 67 68 93 94 O
within 69 75 95 101 O
4 76 77 102 103 O
weeks 78 83 104 109 O
of 84 86 110 112 O
enrollment 87 97 113 123 O
or 98 100 124 126 O
unrecovered 101 112 127 138 O
AEs 113 116 139 142 O
due 117 120 143 146 O
to 121 123 147 149 O
agents 124 130 150 156 O
administered 131 143 157 169 O
more 144 148 170 174 O
than 149 153 175 179 O
4 154 155 180 181 O
weeks 156 161 182 187 O
of 162 164 188 190 O
enrollment 165 175 191 201 O

All 0 3 202 205 O
herbal 4 10 206 212 B-treatment
, 10 11 212 213 O
alternative 12 23 214 225 B-treatment
and 24 27 226 229 O
food 28 32 230 234 B-treatment
supplements 33 44 235 246 I-treatment
( 45 46 247 248 O
i.e. 46 50 248 252 O
, 50 51 252 253 O
PC 52 54 254 256 B-treatment
- 54 55 256 257 I-treatment
Spes 55 59 257 261 I-treatment
, 59 60 261 262 O
Saw 61 64 263 266 B-treatment
Palmetto 65 73 267 275 I-treatment
, 73 74 275 276 O
St 75 77 277 279 B-treatment
John 78 82 280 284 I-treatment
Wort 83 87 285 289 I-treatment
, 87 88 289 290 O
etc 89 92 291 294 O
. 92 93 294 295 O
) 93 94 295 296 O
. 94 95 296 297 O
They 96 100 298 302 O
must 101 105 303 307 O
be 106 108 308 310 O
discontinued 109 121 311 323 O
prior 122 127 324 329 O
to 128 130 330 332 O
enrollment 131 141 333 343 O
. 141 142 343 344 O
Patients 143 151 345 353 O
may 152 155 354 357 O
continue 156 164 358 366 O
on 165 167 367 369 O
a 168 169 370 371 O
daily 170 175 372 377 O
Multi 176 181 378 383 B-treatment
- 181 182 383 384 I-treatment
Vitamin 182 189 384 391 I-treatment
, 189 190 391 392 O
calcium 191 198 393 400 B-treatment
and 199 202 401 404 O
Vitamin 203 210 405 412 B-treatment
D 211 212 413 414 I-treatment

At 0 2 415 417 O
least 3 8 418 423 O
4 9 10 424 425 B-lower_bound
weeks 11 16 426 431 I-lower_bound
from 17 21 432 436 O
prior 22 27 437 442 B-treatment
therapy 28 35 443 450 I-treatment
completion 36 46 451 461 O
( 47 48 462 463 O
including 48 57 463 472 O
radiation 58 67 473 482 B-treatment
and/or 68 74 483 489 O
surgery 75 82 490 497 B-treatment
) 82 83 497 498 O
to 84 86 499 501 O
enrollment 87 97 502 512 O

Clinically 0 10 513 523 O
stable 11 17 524 530 O
CNS 18 21 531 534 B-cancer
tumor 22 27 535 540 I-cancer
at 28 30 541 543 O
the 31 34 544 547 O
time 35 39 548 552 O
of 40 42 553 555 O
screening 43 52 556 565 O
and 53 56 566 569 O
not 57 60 570 573 O
receiving 61 70 574 583 O
steroids 71 79 584 592 B-treatment
and/or 80 86 593 599 O
enzyme 87 93 600 606 B-treatment
- 93 94 606 607 I-treatment
inducing 94 102 607 615 I-treatment
anti 103 107 616 620 I-treatment
- 107 108 620 621 I-treatment
epileptic 108 117 621 630 I-treatment
medications 118 129 631 642 I-treatment
for 130 133 643 646 O
brain 134 139 647 652 B-cancer
metastases 140 150 653 663 I-cancer

ECOG 0 4 664 668 B-clinical_variable
performance 5 16 669 680 I-clinical_variable
status 17 23 681 687 I-clinical_variable
of 24 26 688 690 O
0 27 28 691 692 B-lower_bound
- 28 29 692 693 O
1 29 30 693 694 B-upper_bound

Have 0 4 695 699 O
testosterone 5 17 700 712 B-clinical_variable
< 18 19 713 714 O
50 20 22 715 717 B-upper_bound
ng 23 25 718 720 I-upper_bound
/ 25 26 720 721 I-upper_bound
dL 26 28 721 723 I-upper_bound

Histological 0 12 724 736 O
or 13 15 737 739 O
cytological 16 27 740 751 O
proof 28 33 752 757 O
of 34 36 758 760 O
prostate 37 45 761 769 B-cancer
cancer 46 52 770 776 I-cancer

History 0 7 777 784 O
of 8 10 785 787 O
hypersensitivity 11 27 788 804 O
to 28 30 805 807 O
ribociclib 31 41 808 818 B-allergy_name
or 42 44 819 821 O
compounds 45 54 822 831 O
of 55 57 832 834 O
similar 58 65 835 842 O
chemical 66 74 843 851 O
or 75 77 852 854 O
biologic 78 86 855 863 O
composition 87 98 864 875 O
to 99 101 876 878 O
ribociclib 102 112 879 889 O
including 113 122 890 899 O
to 123 125 900 902 O
peanut 126 132 903 909 B-allergy_name
and 133 136 910 913 O
soy 137 140 914 917 B-allergy_name
or 141 143 918 920 O
other 144 149 921 926 O
drugs 150 155 927 932 O
formulated 156 166 933 943 O
with 167 171 944 948 O
polysorbate 172 183 949 960 B-allergy_name
80 184 186 961 963 I-allergy_name
; 186 187 963 964 O
or 188 190 965 967 O
enzalutamide 191 203 968 980 B-allergy_name

History 0 7 981 988 O
of 8 10 989 991 O
pituitary 11 20 992 1001 B-chronic_disease
or 21 23 1002 1004 O
adrenal 24 31 1005 1012 B-chronic_disease
dysfunction 32 43 1013 1024 I-chronic_disease
, 43 44 1024 1025 O
active 45 51 1026 1032 O
or 52 54 1033 1035 O
symptomatic 55 66 1036 1047 O
viral 67 72 1048 1053 O
hepatitis 73 82 1054 1063 B-chronic_disease
or 83 85 1064 1066 O
chronic 86 93 1067 1074 B-chronic_disease
liver 94 99 1075 1080 I-chronic_disease
disease 100 107 1081 1088 I-chronic_disease

Hormonal 0 8 1089 1097 B-treatment
- 8 9 1097 1098 I-treatment
acting 9 15 1098 1104 I-treatment
agents 16 22 1105 1111 I-treatment
( 23 24 1112 1113 O
including 24 33 1113 1122 O
DES 34 37 1123 1126 B-treatment
, 37 38 1126 1127 O
aldosterone 39 50 1128 1139 B-treatment
, 50 51 1139 1140 O
and 52 55 1141 1144 O
spironolactone 56 70 1145 1159 B-treatment
but 71 74 1160 1163 O
not 75 78 1164 1167 O
including 79 88 1168 1177 O
GnRH 89 93 1178 1182 B-treatment
agonists 94 102 1183 1191 I-treatment
or 103 105 1192 1194 I-treatment
antagonists 106 117 1195 1206 I-treatment
) 117 118 1206 1207 O
are 119 122 1208 1211 O
forbidden 123 132 1212 1221 O
during 133 139 1222 1228 O
the 140 143 1229 1232 O
trial 144 149 1233 1238 O
and 150 153 1239 1242 O
must 154 158 1243 1247 O
be 159 161 1248 1250 O
stopped 162 169 1251 1258 O
prior 170 175 1259 1264 O
to 176 178 1265 1267 O
enrollment 179 189 1268 1278 O
. 189 190 1278 1279 O
No 191 193 1280 1282 O
washout 194 201 1283 1290 O
period 202 208 1291 1297 O
will 209 213 1298 1302 O
be 214 216 1303 1305 O
required 217 225 1306 1314 O
for 226 229 1315 1318 O
any 230 233 1319 1322 O
of 234 236 1323 1325 O
these 237 242 1326 1331 O
agents 243 249 1332 1338 O

Initiation 0 10 1339 1349 O
of 11 13 1350 1352 O
bisphosphonate 14 28 1353 1367 B-treatment
/ 28 29 1367 1368 I-treatment
denosumab 29 38 1368 1377 I-treatment
therapy 39 46 1378 1385 I-treatment
during 47 53 1386 1392 O
protocol 54 62 1393 1401 B-treatment
treatment 63 72 1402 1411 I-treatment

Initiation 0 10 1412 1422 O
of 11 13 1423 1425 O
bisphosphonate 14 28 1426 1440 B-treatment
/ 28 29 1440 1441 O
denosumab 29 38 1441 1450 B-treatment
therapy 39 46 1451 1458 I-treatment
will 47 51 1459 1463 O
be 52 54 1464 1466 O
allowed 55 62 1467 1474 O
for 63 66 1475 1478 O
the 67 70 1479 1482 O
treatment 71 80 1483 1492 B-treatment
of 81 83 1493 1495 O
osteoporosis 84 96 1496 1508 B-chronic_disease
or 97 99 1509 1511 O
prevention 100 110 1512 1522 O
of 111 113 1523 1525 O
skeletal 114 122 1526 1534 B-chronic_disease
- 122 123 1534 1535 I-chronic_disease
related 123 130 1535 1542 I-chronic_disease
events 131 137 1543 1549 I-chronic_disease
( 138 139 1550 1551 I-chronic_disease
SRE 139 142 1551 1554 I-chronic_disease
) 142 143 1554 1555 I-chronic_disease
during 144 150 1556 1562 O
protocol 151 159 1563 1571 O
treatment 160 169 1572 1581 O

Known 0 5 1582 1587 O
symptomatic 6 17 1588 1599 O
brain 18 23 1600 1605 B-cancer
metastases 24 34 1606 1616 I-cancer

Males 0 5 1617 1622 B-gender

Men 0 3 1623 1626 B-gender
must 4 8 1627 1631 O
agree 9 14 1632 1637 B-contraception_consent
to 15 17 1638 1640 I-contraception_consent
use 18 21 1641 1644 I-contraception_consent
adequate 22 30 1645 1653 I-contraception_consent
contraception 31 44 1654 1667 I-contraception_consent
prior 45 50 1668 1673 O
to 51 53 1674 1676 O
enrollment 54 64 1677 1687 O
, 64 65 1687 1688 O
for 66 69 1689 1692 O
the 70 73 1693 1696 O
duration 74 82 1697 1705 O
of 83 85 1706 1708 O
study 86 91 1709 1714 O
participation 92 105 1715 1728 O
and 106 109 1729 1732 O
for 110 113 1733 1736 O
at 114 116 1737 1739 O
least 117 122 1740 1745 O
3 123 124 1746 1747 B-lower_bound
months 125 131 1748 1754 I-lower_bound
thereafter 132 142 1755 1765 O

Must 0 4 1766 1770 O
be 5 7 1771 1773 O
able 8 12 1774 1778 O
to 13 15 1779 1781 O
take 16 20 1782 1786 O
oral 21 25 1787 1791 B-treatment
medication 26 36 1792 1802 I-treatment
without 37 44 1803 1810 O
crushing 45 53 1811 1819 O
, 53 54 1819 1820 O
dissolving 55 65 1821 1831 O
or 66 68 1832 1834 O
chewing 69 76 1835 1842 O
tablets 77 84 1843 1850 O

On 0 2 1851 1853 O
screening 3 12 1854 1863 O
, 12 13 1863 1864 O
inability 14 23 1865 1874 O
to 24 26 1875 1877 O
determine 27 36 1878 1887 O
the 37 40 1888 1891 O
QTcF 41 45 1892 1896 B-clinical_variable
interval 46 54 1897 1905 I-clinical_variable
on 55 57 1906 1908 O
the 58 61 1909 1912 O
ECG 62 65 1913 1916 B-treatment
( 66 67 1917 1918 O
i.e. 67 71 1918 1922 O
: 71 72 1922 1923 O
unreadable 73 83 1924 1934 O
or 84 86 1935 1937 O
not 87 90 1938 1941 O
interpretable 91 104 1942 1955 O
) 104 105 1955 1956 O
or 106 108 1957 1959 O
QTcF 109 113 1960 1964 O
> 114 115 1965 1966 O
450 115 118 1966 1969 B-lower_bound
msec 119 123 1970 1974 I-lower_bound
( 124 125 1975 1976 O
using 125 130 1976 1981 O
Fridericia 131 141 1982 1992 O
's 141 143 1992 1994 O
correction 144 154 1995 2005 O
) 154 155 2005 2006 O
. 155 156 2006 2007 O
All 157 160 2008 2011 O
as 161 163 2012 2014 O
determined 164 174 2015 2025 O
by 175 177 2026 2028 O
screening 178 187 2029 2038 O
ECG 188 191 2039 2042 O
( 192 193 2043 2044 O
mean 193 197 2044 2048 O
of 198 200 2049 2051 O
triplicate 201 211 2052 2062 O
ECGs 212 216 2063 2067 O

Patient 0 7 2068 2075 O
has 8 11 2076 2079 O
a 12 13 2080 2081 O
concurrent 14 24 2082 2092 O
malignancy 25 35 2093 2103 B-cancer
or 36 38 2104 2106 O
malignancy 39 49 2107 2117 O
within 50 56 2118 2124 O
3 57 58 2125 2126 B-upper_bound
years 59 64 2127 2132 I-upper_bound
of 65 67 2133 2135 O
enrollment 68 78 2136 2146 O

Patient 0 7 2147 2154 O
has 8 11 2155 2158 O
a 12 13 2159 2160 O
history 14 21 2161 2168 O
of 22 24 2169 2171 O
non 25 28 2172 2175 O
- 28 29 2175 2176 O
compliance 29 39 2176 2186 O
to 40 42 2187 2189 O
medical 43 50 2190 2197 B-treatment
regimen 51 58 2198 2205 I-treatment
or 59 61 2206 2208 O
inability 62 71 2209 2218 O
to 72 74 2219 2221 O
grant 75 80 2222 2227 O
consent 81 88 2228 2235 O

Patient 0 7 2236 2243 O
has 8 11 2244 2247 O
a 12 13 2248 2249 O
known 14 19 2250 2255 O
history 20 27 2256 2263 O
of 28 30 2264 2266 O
HIV 31 34 2267 2270 B-chronic_disease
infection 35 44 2271 2280 I-chronic_disease
( 45 46 2281 2282 O
testing 46 53 2282 2289 O
not 54 57 2290 2293 O
mandatory 58 67 2294 2303 O
) 67 68 2303 2304 O

Patient 0 7 2305 2312 O
has 8 11 2313 2316 O
any 12 15 2317 2320 O
other 16 21 2321 2326 O
concurrent 22 32 2327 2337 O
severe 33 39 2338 2344 O
and/or 40 46 2345 2351 O
uncontrolled 47 59 2352 2364 O
medical 60 67 2365 2372 B-chronic_disease
condition 68 77 2373 2382 I-chronic_disease
that 78 82 2383 2387 O
would 83 88 2388 2393 O
, 88 89 2393 2394 O
in 90 92 2395 2397 O
the 93 96 2398 2401 O
investigator 97 109 2402 2414 O
's 109 111 2414 2416 O
judgment 112 120 2417 2425 O
, 120 121 2425 2426 O
cause 122 127 2427 2432 O
unacceptable 128 140 2433 2445 O
safety 141 147 2446 2452 O
risks 148 153 2453 2458 O
, 153 154 2458 2459 O
contraindicate 155 169 2460 2474 O
patient 170 177 2475 2482 O
participation 178 191 2483 2496 O
in 192 194 2497 2499 O
the 195 198 2500 2503 O
clinical 199 207 2504 2512 O
study 208 213 2513 2518 O
or 214 216 2519 2521 O
compromise 217 227 2522 2532 O
compliance 228 238 2533 2543 O
with 239 243 2544 2548 O
the 244 247 2549 2552 O
protocol 248 256 2553 2561 O
( 257 258 2562 2563 O
e.g. 258 262 2563 2567 O
, 262 263 2567 2568 O
chronic 264 271 2569 2576 B-chronic_disease
pancreatitis 272 284 2577 2589 I-chronic_disease
, 284 285 2589 2590 O
chronic 286 293 2591 2598 B-chronic_disease
active 294 300 2599 2605 I-chronic_disease
hepatitis 301 310 2606 2615 I-chronic_disease
, 310 311 2615 2616 O
active 312 318 2617 2623 O
untreated 319 328 2624 2633 O
or 329 331 2634 2636 O
uncontrolled 332 344 2637 2649 O
fungal 345 351 2650 2656 B-chronic_disease
, 351 352 2656 2657 O
bacterial 353 362 2658 2667 B-chronic_disease
or 363 365 2668 2670 O
viral 366 371 2671 2676 B-chronic_disease
infections 372 382 2677 2687 I-chronic_disease
, 382 383 2687 2688 O
etc 384 387 2689 2692 O
. 387 388 2692 2693 O
) 388 389 2693 2694 O

Patient 0 7 2695 2702 O
has 8 11 2703 2706 O
had 12 15 2707 2710 O
major 16 21 2711 2716 B-treatment
surgery 22 29 2717 2724 I-treatment
within 30 36 2725 2731 O
14 37 39 2732 2734 B-upper_bound
days 40 44 2735 2739 I-upper_bound
prior 45 50 2740 2745 I-upper_bound
to 51 53 2746 2748 O
enrollment 54 64 2749 2759 O
or 65 67 2760 2762 O
has 68 71 2763 2766 O
not 72 75 2767 2770 O
recovered 76 85 2771 2780 O
from 86 90 2781 2785 O
major 91 96 2786 2791 O
side 97 101 2792 2796 O
effects 102 109 2797 2804 O
( 110 111 2805 2806 O
tumor 111 116 2806 2811 B-treatment
biopsy 117 123 2812 2818 I-treatment
is 124 126 2819 2821 O
not 127 130 2822 2825 O
considered 131 141 2826 2836 O
as 142 144 2837 2839 O
major 145 150 2840 2845 O
surgery 151 158 2846 2853 O
) 158 159 2853 2854 O

Patient 0 7 2855 2862 O
has 8 11 2863 2866 O
impairment 12 22 2867 2877 B-chronic_disease
of 23 25 2878 2880 I-chronic_disease
gastrointestinal 26 42 2881 2897 I-chronic_disease
( 43 44 2898 2899 I-chronic_disease
GI 44 46 2899 2901 I-chronic_disease
) 46 47 2901 2902 I-chronic_disease
function 48 56 2903 2911 I-chronic_disease
or 57 59 2912 2914 O
GI 60 62 2915 2917 B-chronic_disease
disease 63 70 2918 2925 I-chronic_disease
that 71 75 2926 2930 O
may 76 79 2931 2934 O
significantly 80 93 2935 2948 O
alter 94 99 2949 2954 O
the 100 103 2955 2958 O
absorption 104 114 2959 2969 O
of 115 117 2970 2972 O
the 118 121 2973 2976 O
study 122 127 2977 2982 B-treatment
drugs 128 133 2983 2988 I-treatment
( 134 135 2989 2990 O
e.g. 135 139 2990 2994 O
, 139 140 2994 2995 O
ulcerative 141 151 2996 3006 B-chronic_disease
diseases 152 160 3007 3015 I-chronic_disease
, 160 161 3015 3016 O
uncontrolled 162 174 3017 3029 O
nausea 175 181 3030 3036 O
, 181 182 3036 3037 O
vomiting 183 191 3038 3046 O
, 191 192 3046 3047 O
diarrhea 193 201 3048 3056 B-chronic_disease
, 201 202 3056 3057 O
malabsorption 203 216 3058 3071 B-chronic_disease
syndrome 217 225 3072 3080 I-chronic_disease
, 225 226 3080 3081 O
or 227 229 3082 3084 O
small 230 235 3085 3090 B-chronic_disease
bowel 236 241 3091 3096 I-chronic_disease
resection 242 251 3097 3106 I-chronic_disease
) 251 252 3106 3107 O

Patient 0 7 3108 3115 O
has 8 11 3116 3119 O
not 12 15 3120 3123 O
recovered 16 25 3124 3133 O
from 26 30 3134 3138 O
all 31 34 3139 3142 O
toxicities 35 45 3143 3153 O
related 46 53 3154 3161 O
to 54 56 3162 3164 O
prior 57 62 3165 3170 B-treatment
anticancer 63 73 3171 3181 I-treatment
therapies 74 83 3182 3191 I-treatment
to 84 86 3192 3194 O
NCI 87 90 3195 3198 B-clinical_variable
- 90 91 3198 3199 I-clinical_variable
CTCAE 91 96 3199 3204 I-clinical_variable
version 97 104 3205 3212 I-clinical_variable
4.03 105 109 3213 3217 I-clinical_variable
Grade 110 115 3218 3223 I-clinical_variable
< 116 117 3224 3225 O
1 117 118 3225 3226 B-upper_bound

Patient 0 7 3227 3234 O
is 8 10 3235 3237 O
currently 11 20 3238 3247 O
receiving 21 30 3248 3257 O
or 31 33 3258 3260 O
has 34 37 3261 3264 O
received 38 46 3265 3273 O
systemic 47 55 3274 3282 B-treatment
corticosteroids 56 71 3283 3298 I-treatment
within 72 78 3299 3305 O
< 79 80 3306 3307 O
2 80 81 3307 3308 B-upper_bound
weeks 82 87 3309 3314 I-upper_bound
prior 88 93 3315 3320 I-upper_bound
to 94 96 3321 3323 O
enrollment 97 107 3324 3334 O
, 107 108 3334 3335 O
or 109 111 3336 3338 O
who 112 115 3339 3342 O
have 116 120 3343 3347 O
not 121 124 3348 3351 O
fully 125 130 3352 3357 O
recovered 131 140 3358 3367 O
from 141 145 3368 3372 O
side 146 150 3373 3377 O
effects 151 158 3378 3385 O
of 159 161 3386 3388 O
such 162 166 3389 3393 O
treatment 167 176 3394 3403 B-treatment

Patient 0 7 3404 3411 O
is 8 10 3412 3414 O
currently 11 20 3415 3424 O
receiving 21 30 3425 3434 O
warfarin 31 39 3435 3443 B-treatment
or 40 42 3444 3446 O
other 43 48 3447 3452 O
coumarin 49 57 3453 3461 O
- 57 58 3461 3462 O
derived 58 65 3462 3469 O
anticoagulant 66 79 3470 3483 B-treatment
for 80 83 3484 3487 O
treatment 84 93 3488 3497 B-treatment
, 93 94 3497 3498 O
prophylaxis 95 106 3499 3510 B-treatment
or 107 109 3511 3513 O
otherwise 110 119 3514 3523 O

Patient 0 7 3524 3531 O
who 8 11 3532 3535 O
has 12 15 3536 3539 O
participated 16 28 3540 3552 O
in 29 31 3553 3555 O
a 32 33 3556 3557 O
prior 34 39 3558 3563 B-treatment
investigational 40 55 3564 3579 I-treatment
study 56 61 3580 3585 I-treatment
within 62 68 3586 3592 O
30 69 71 3593 3595 B-upper_bound
days 72 76 3596 3600 I-upper_bound
prior 77 82 3601 3606 I-upper_bound
to 83 85 3607 3609 O
enrollment 86 96 3610 3620 O
or 97 99 3621 3623 O
within 100 106 3624 3630 O
5 107 108 3631 3632 B-upper_bound
half 109 113 3633 3637 I-upper_bound
- 113 114 3637 3638 I-upper_bound
lives 114 119 3638 3643 I-upper_bound
of 120 122 3644 3646 O
the 123 126 3647 3650 O
investigational 127 142 3651 3666 B-treatment
product 143 150 3667 3674 I-treatment
, 150 151 3674 3675 O
whichever 152 161 3676 3685 O
is 162 164 3686 3688 O
longer 165 171 3689 3695 O

Patient 0 7 3696 3703 O
who 8 11 3704 3707 O
has 12 15 3708 3711 O
received 16 24 3712 3720 O
radiotherapy 25 37 3721 3733 B-treatment
≤ 38 39 3734 3735 O
4 40 41 3736 3737 B-upper_bound
weeks 42 47 3738 3743 I-upper_bound
or 48 50 3744 3746 O
limited 51 58 3747 3754 O
field 59 64 3755 3760 O
radiation 65 74 3761 3770 B-treatment
for 75 78 3771 3774 I-treatment
palliation 79 89 3775 3785 I-treatment
≤ 90 91 3786 3787 O
2 92 93 3788 3789 B-upper_bound
weeks 94 99 3790 3795 I-upper_bound
prior 100 105 3796 3801 I-upper_bound
to 106 108 3802 3804 O
enrollment 109 119 3805 3815 O
, 119 120 3815 3816 O
and 121 124 3817 3820 O
who 125 128 3821 3824 O
has 129 132 3825 3828 O
not 133 136 3829 3832 O
recovered 137 146 3833 3842 O
to 147 149 3843 3845 O
Grade 150 155 3846 3851 O
1 156 157 3852 3853 O
or 158 160 3854 3856 O
better 161 167 3857 3863 O
from 168 172 3864 3868 O
related 173 180 3869 3876 O
side 181 185 3877 3881 O
effects 186 193 3882 3889 O
of 194 196 3890 3892 O
such 197 201 3893 3897 O
therapy 202 209 3898 3905 O
( 210 211 3906 3907 O
exceptions 211 221 3907 3917 O
include 222 229 3918 3925 O
alopecia 230 238 3926 3934 B-chronic_disease
) 238 239 3934 3935 O
and/or 240 246 3936 3942 O
in 247 249 3943 3945 O
whom 250 254 3946 3950 O
≥ 255 256 3951 3952 O
30 257 259 3953 3955 B-lower_bound
% 259 260 3955 3956 I-lower_bound
of 261 263 3957 3959 O
the 264 267 3960 3963 O
bone 268 272 3964 3968 O
marrow 273 279 3969 3975 O
was 280 283 3976 3979 O
irradiated 284 294 3980 3990 O

Patients 0 8 3991 3999 O
must 9 13 4000 4004 O
continue 14 22 4005 4013 O
primary 23 30 4014 4021 B-treatment
androgen 31 39 4022 4030 I-treatment
deprivation 40 51 4031 4042 I-treatment
with 52 56 4043 4047 O
an 57 59 4048 4050 O
LHRH 60 64 4051 4055 B-treatment
analogue 65 73 4056 4064 I-treatment
( 74 75 4065 4066 I-treatment
agonist 75 82 4066 4073 I-treatment
or 83 85 4074 4076 I-treatment
antagonist 86 96 4077 4087 I-treatment
) 96 97 4087 4088 I-treatment
if 98 100 4089 4091 O
they 101 105 4092 4096 O
have 106 110 4097 4101 O
not 111 114 4102 4105 O
undergone 115 124 4106 4115 O
orchiectomy 125 136 4116 4127 B-treatment

Patients 0 8 4128 4136 O
on 9 11 4137 4139 O
long 12 16 4140 4144 O
term 17 21 4145 4149 O
( 22 23 4150 4151 O
> 23 24 4151 4152 O
6 24 25 4152 4153 O
months 26 32 4154 4160 O
) 32 33 4160 4161 O
anti 34 38 4162 4166 B-treatment
- 38 39 4166 4167 I-treatment
androgen 39 47 4167 4175 I-treatment
therapy 48 55 4176 4183 I-treatment
( 56 57 4184 4185 O
e.g. 57 61 4185 4189 O
, 61 62 4189 4190 O
flutamide 63 72 4191 4200 B-treatment
, 72 73 4200 4201 O
bicalutamide 74 86 4202 4214 B-treatment
, 86 87 4214 4215 O
nilutamide 88 98 4216 4226 B-treatment
) 98 99 4226 4227 O
will 100 104 4228 4232 O
need 105 109 4233 4237 O
to 110 112 4238 4240 O
be 113 115 4241 4243 O
off 116 119 4244 4247 O
anti 120 124 4248 4252 O
- 124 125 4252 4253 O
androgen 125 133 4253 4261 O
for 134 137 4262 4265 O
4 138 139 4266 4267 B-upper_bound
weeks 140 145 4268 4273 I-upper_bound
( 146 147 4274 4275 O
wash 147 151 4275 4279 O
out 152 155 4280 4283 O
period 156 162 4284 4290 O
) 162 163 4290 4291 O
and 164 167 4292 4295 O
show 168 172 4296 4300 O
evidence 173 181 4301 4309 O
of 182 184 4310 4312 O
disease 185 192 4313 4320 O
progression 193 204 4321 4332 O
off 205 208 4333 4336 O
the 209 212 4337 4340 O
anti 213 217 4341 4345 O
- 217 218 4345 4346 O
androgen 218 226 4346 4354 O
. 226 227 4354 4355 O
Patients 228 236 4356 4364 O
that 237 241 4365 4369 O
have 242 246 4370 4374 O
been 247 251 4375 4379 O
on 252 254 4380 4382 O
an 255 257 4383 4385 O
anti 258 262 4386 4390 O
- 262 263 4390 4391 O
androgen 263 271 4391 4399 O
6 272 273 4400 4401 O
months 274 280 4402 4408 O
or 281 283 4409 4411 O
less 284 288 4412 4416 O
will 289 293 4417 4421 O
need 294 298 4422 4426 O
to 299 301 4427 4429 O
discontinue 302 313 4430 4441 O
anti 314 318 4442 4446 O
- 318 319 4446 4447 O
androgen 319 327 4447 4455 O
therapy 328 335 4456 4463 O
prior 336 341 4464 4469 O
to 342 344 4470 4472 O
enrollment 345 355 4473 4483 O
( 356 357 4484 4485 O
no 357 359 4485 4487 O
wash 360 364 4488 4492 O
out 365 368 4493 4496 O
period 369 375 4497 4503 O
required 376 384 4504 4512 O
) 384 385 4512 4513 O

Patients 0 8 4514 4522 O
on 9 11 4523 4525 O
stable 12 18 4526 4532 O
doses 19 24 4533 4538 O
of 25 27 4539 4541 O
bisphosphonates 28 43 4542 4557 B-treatment
or 44 46 4558 4560 O
denosumab 47 56 4561 4570 B-treatment
which 57 62 4571 4576 O
have 63 67 4577 4581 O
been 68 72 4582 4586 O
started 73 80 4587 4594 O
no 81 83 4595 4597 O
less 84 88 4598 4602 O
than 89 93 4603 4607 O
4 94 95 4608 4609 B-upper_bound
weeks 96 101 4610 4615 I-upper_bound
prior 102 107 4616 4621 I-upper_bound
to 108 110 4622 4624 O
enrollment 111 121 4625 4635 O
may 122 125 4636 4639 O
continue 126 134 4640 4648 O
on 135 137 4649 4651 O
this 138 142 4652 4656 O
medication 143 153 4657 4667 B-treatment

Peripheral 0 10 4668 4678 B-clinical_variable
neuropathy 11 21 4679 4689 I-clinical_variable
> 22 23 4690 4691 O
2 24 25 4692 4693 B-lower_bound

Planned 0 7 4694 4701 B-treatment
surgery 8 15 4702 4709 I-treatment
or 16 18 4710 4712 O
radiation 19 28 4713 4722 B-treatment
therapy 29 36 4723 4730 I-treatment
during 37 43 4731 4737 O
protocol 44 52 4738 4746 B-treatment
treatment 53 62 4747 4756 I-treatment

Prior 0 5 4757 4762 B-treatment
chemotherapy 6 18 4763 4775 I-treatment

Prior 0 5 4776 4781 O
exposure 6 14 4782 4790 O
to 15 17 4791 4793 O
abiraterone 18 29 4794 4805 B-treatment
acetate 30 37 4806 4813 I-treatment
or 38 40 4814 4816 O
other 41 46 4817 4822 O
specific 47 55 4823 4831 O
CYP-17 56 62 4832 4838 B-treatment
inhibitors 63 73 4839 4849 I-treatment

Prior 0 5 4850 4855 O
exposure 6 14 4856 4864 O
to 15 17 4865 4867 O
enzalutamide 18 30 4868 4880 B-treatment
or 31 33 4881 4883 O
other 34 39 4884 4889 O
investigational 40 55 4890 4905 B-treatment
AR 56 58 4906 4908 I-treatment
directed 59 67 4909 4917 I-treatment
therapy 68 75 4918 4925 I-treatment

Prior 0 5 4926 4931 B-treatment
isotope 6 13 4932 4939 I-treatment
therapy 14 21 4940 4947 I-treatment
with 22 26 4948 4952 I-treatment
strontium-89 27 39 4953 4965 I-treatment
, 39 40 4965 4966 I-treatment
samarium 41 49 4967 4975 I-treatment
or 50 52 4976 4978 I-treatment
radium-223 53 63 4979 4989 I-treatment
within 64 70 4990 4996 O
12 71 73 4997 4999 B-upper_bound
weeks 74 79 5000 5005 I-upper_bound
of 80 82 5006 5008 O
enrollment 83 93 5009 5019 O

Sexually 0 8 5020 5028 O
active 9 15 5029 5035 O
males 16 21 5036 5041 B-gender
unless 22 28 5042 5048 O
they 29 33 5049 5053 O
use 34 37 5054 5057 B-contraception_consent
a 38 39 5058 5059 I-contraception_consent
condom 40 46 5060 5066 I-contraception_consent
during 47 53 5067 5073 O
intercourse 54 65 5074 5085 O
while 66 71 5086 5091 O
taking 72 78 5092 5098 O
the 79 82 5099 5102 O
drug 83 87 5103 5107 O
and 88 91 5108 5111 O
for 92 95 5112 5115 O
30 96 98 5116 5118 B-upper_bound
days 99 103 5119 5123 I-upper_bound
after 104 109 5124 5129 I-upper_bound
stopping 110 118 5130 5138 O
treatment 119 128 5139 5148 B-treatment
and 129 132 5149 5152 O
should 133 139 5153 5159 O
not 140 143 5160 5163 O
father 144 150 5164 5170 O
a 151 152 5171 5172 O
child 153 158 5173 5178 O
in 159 161 5179 5181 O
this 162 166 5182 5186 O
period 167 173 5187 5193 O
. 173 174 5193 5194 O
A 175 176 5195 5196 O
condom 177 183 5197 5203 O
is 184 186 5204 5206 O
required 187 195 5207 5215 O
to 196 198 5216 5218 O
be 199 201 5219 5221 O
used 202 206 5222 5226 O
by 207 209 5227 5229 O
vasectomized 210 222 5230 5242 O
men 223 226 5243 5246 O
in 227 229 5247 5249 O
order 230 235 5250 5255 O
to 236 238 5256 5258 O
prevent 239 246 5259 5266 O
delivery 247 255 5267 5275 O
of 256 258 5276 5278 O
the 259 262 5279 5282 O
drug 263 267 5283 5287 O
via 268 271 5288 5291 O
seminal 272 279 5292 5299 O
fluid 280 285 5300 5305 O

The 0 3 5306 5309 O
effects 4 11 5310 5317 O
of 12 14 5318 5320 O
ribociclib 15 25 5321 5331 B-treatment
on 26 28 5332 5334 O
the 29 32 5335 5338 O
developing 33 43 5339 5349 O
human 44 49 5350 5355 O
fetus 50 55 5356 5361 O
at 56 58 5362 5364 O
the 59 62 5365 5368 O
recommended 63 74 5369 5380 O
therapeutic 75 86 5381 5392 O
dose 87 91 5393 5397 O
are 92 95 5398 5401 O
unknown 96 103 5402 5409 O

The 0 3 5410 5413 O
following 4 13 5414 5423 O
uses 14 18 5424 5428 O
of 19 21 5429 5431 O
corticosteroids 22 37 5432 5447 B-treatment
are 38 41 5448 5451 O
permitted 42 51 5452 5461 O
: 51 52 5461 5462 O
single 53 59 5463 5469 O
doses 60 65 5470 5475 O
, 65 66 5475 5476 O
topical 67 74 5477 5484 B-treatment
applications 75 87 5485 5497 I-treatment
( 88 89 5498 5499 O
e.g. 89 93 5499 5503 O
, 93 94 5503 5504 O
for 95 98 5505 5508 O
rash 99 103 5509 5513 O
) 103 104 5513 5514 O
, 104 105 5514 5515 O
inhaled 106 113 5516 5523 B-treatment
sprays 114 120 5524 5530 I-treatment
( 121 122 5531 5532 O
e.g. 122 126 5532 5536 O
, 126 127 5536 5537 O
for 128 131 5538 5541 O
obstructive 132 143 5542 5553 B-chronic_disease
airways 144 151 5554 5561 I-chronic_disease
diseases 152 160 5562 5570 I-chronic_disease
) 160 161 5570 5571 O
, 161 162 5571 5572 O
eye 163 166 5573 5576 B-treatment
drops 167 172 5577 5582 I-treatment
or 173 175 5583 5585 O
local 176 181 5586 5591 B-treatment
injections 182 192 5592 5602 I-treatment
( 193 194 5603 5604 O
e.g. 194 198 5604 5608 O
, 198 199 5608 5609 O
intra 200 205 5610 5615 B-treatment
- 205 206 5615 5616 I-treatment
articular 206 215 5616 5625 I-treatment
) 215 216 5625 5626 O

Therapy 0 7 5627 5634 B-treatment
with 8 12 5635 5639 O
heparin 13 20 5640 5647 B-treatment
, 20 21 5647 5648 O
low 22 25 5649 5652 B-treatment
molecular 26 35 5653 5662 I-treatment
weight 36 42 5663 5669 I-treatment
heparin 43 50 5670 5677 I-treatment
( 51 52 5678 5679 I-treatment
LMWH 52 56 5679 5683 I-treatment
) 56 57 5683 5684 I-treatment
or 58 60 5685 5687 O
fondaparinux 61 73 5688 5700 B-treatment

Treatment 0 9 5701 5710 B-treatment
- 9 10 5710 5711 O
related 10 17 5711 5718 O
toxicity 18 26 5719 5727 O
from 27 31 5728 5732 O
prior 32 37 5733 5738 B-treatment
therapy 38 45 5739 5746 I-treatment
> 46 47 5747 5748 O
Grade 48 53 5749 5754 B-lower_bound
2 54 55 5755 5756 I-lower_bound

Use 0 3 5757 5760 O
of 4 6 5761 5763 O
any 7 10 5764 5767 O
prohibited 11 21 5768 5778 O
concomitant 22 33 5779 5790 B-treatment
medications 34 45 5791 5802 I-treatment
: 45 46 5802 5803 O
immunotherapy 47 60 5804 5817 B-treatment
, 60 61 5817 5818 O
5 62 63 5819 5820 B-treatment
alpha 64 69 5821 5826 I-treatment
reductase 70 79 5827 5836 I-treatment
inhibitors 80 90 5837 5847 I-treatment
, 90 91 5847 5848 O
spironolactone 92 106 5849 5863 B-treatment
, 106 107 5863 5864 O
diethylstilbestrol 108 126 5865 5883 B-treatment
( 127 128 5884 5885 I-treatment
DES 128 131 5885 5888 I-treatment
) 131 132 5888 5889 I-treatment
, 132 133 5889 5890 O
ketoconazole 134 146 5891 5903 B-treatment
, 146 147 5903 5904 O
newer 148 153 5905 5910 O
medications 154 165 5911 5922 O
targeting 166 175 5923 5932 O
ARs 176 179 5933 5936 O

adequately 0 10 5937 5947 O
treated 11 18 5948 5955 O
, 18 19 5955 5956 O
basal 20 25 5957 5962 B-cancer
or 26 28 5963 5965 O
squamous 29 37 5966 5974 B-cancer
cell 38 42 5975 5979 I-cancer
carcinoma 43 52 5980 5989 I-cancer
, 52 53 5989 5990 O
non 54 57 5991 5994 B-cancer
- 57 58 5994 5995 I-cancer
melanomatous 58 70 5995 6007 I-cancer
skin 71 75 6008 6012 I-cancer
cancer 76 82 6013 6019 I-cancer
or 83 85 6020 6022 O
curatively 86 96 6023 6033 O
resected 97 105 6034 6042 O
cervical 106 114 6043 6051 B-cancer
cancer 115 121 6052 6058 I-cancer

patients 0 8 6059 6067 O
with 9 13 6068 6072 O
any 14 17 6073 6076 O
grade 18 23 6077 6082 O
of 24 26 6083 6085 O
alopecia 27 35 6086 6094 B-chronic_disease

